ResMed | Kostnadene For Salg



Cost Of Sales Endring Dato
Ansell USD 254.1M 232.2M 2024-06
AtriCure USD 31.66M 2.54M 2024-12
Baxter International USD 1.74B 73M 2024-12
Cochlear AUD 269.9M 300K 2024-06
Cooper Companies USD 304.5M 36.2M 2025-01
CSL USD 3.41B 315M 2024-06
Dexcom USD 404.2M 3.8M 2024-12
Edwards Lifesciences USD 292.2M 29.3M 2024-12
Fisher Paykel Healthcare NZD 362.5M 18.3M 2024-09
Globus Medical USD 263.44M 7.08M 2024-12
Haemonetics USD 151.97M 2.34M 2024-12
Hologic USD 441.3M 11M 2024-12
Idexx Laboratories USD 383.63M 4.12M 2024-12
Insulet USD 166.6M 200K 2024-12
Integra LifeSciences USD 176.8M 14.01M 2024-12
Intuitive Surgical USD 771.3M 107.1M 2024-12
Masimo USD 356M 114.6M 2024-12
Medtronic USD 2.78B 160M 2025-01
Philips EUR 3.08B 710M 2024-12
Ramsay Health Care AUD 2.23B 6.3M 2024-12
ResMed USD 530.81M 23.52M 2024-12
Sigma Healthcare AUD 1.72B 188.07M 2024-07
Sonic Healthcare AUD 751.66M 801.13M 2024-12
Steris USD 760.24M 10.12M 2024-12
Teleflex USD 355.49M 21.29M 2024-12
Thermo Fisher Scientific USD 6.57B 303M 2024-12



ResMed Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.